| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 23EDE20K1X |
| InChI Key | GXYZREDEYDFJPT-ZMBIFBSDSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H30ClN5O3 |
| Molecular Weight | 520.03 |
| AlogP | 3.58 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 81.93 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 36.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Serotonin 1a (5-HT1a) receptor antagonist | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107349 |
| EPA CompTox | DTXSID20195826 |
| FDA SRS | 23EDE20K1X |
| PubChem | 11156648 |
| SureChEMBL | SCHEMBL1036321 |